Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 219

1.

Effectiveness of two antifolate prophylactic strategies against malaria in HIV-positive pregnant women in Bangui, Central African Republic: study protocol for a randomized controlled trial (MACOMBA).

Manirakiza A, Sepou A, Serdouma E, Gondje S, Bata GG, Moussa S, Boulay A, Moyen JM, Sakanga O, Le-Fouler L, Kazanji M, Vray M.

Trials. 2013 Aug 14;14:255. doi: 10.1186/1745-6215-14-255.

2.

Effectiveness of co-trimoxazole to prevent Plasmodium falciparum malaria in HIV-positive pregnant women in sub-Saharan Africa: an open-label, randomized controlled trial.

Klement E, Pitché P, Kendjo E, Singo A, D'Almeida S, Akouete F, Akpaloo Y, Tossa K, Prince-Agbodjan S, Patassi A, Caumes E.

Clin Infect Dis. 2014 Mar;58(5):651-9. doi: 10.1093/cid/cit806. Epub 2013 Dec 12.

3.

Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi.

Filler SJ, Kazembe P, Thigpen M, Macheso A, Parise ME, Newman RD, Steketee RW, Hamel M.

J Infect Dis. 2006 Aug 1;194(3):286-93. Epub 2006 Jun 20.

4.
5.

Safety of daily co-trimoxazole in pregnancy in an area of changing malaria epidemiology: a phase 3b randomized controlled clinical trial.

Manyando C, Njunju EM, Mwakazanga D, Chongwe G, Mkandawire R, Champo D, Mulenga M, De Crop M, Claeys Y, Ravinetto RM, van Overmeir C, Alessandro UD, Van Geertruyden JP.

PLoS One. 2014 May 15;9(5):e96017. doi: 10.1371/journal.pone.0096017. eCollection 2014.

6.

Cost-effectiveness of sulfadoxine-pyrimethamine for the prevention of malaria-associated low birth weight.

Wolfe EB, Parise ME, Haddix AC, Nahlen BL, Ayisi JG, Misore A, Steketee RW.

Am J Trop Med Hyg. 2001 Mar-Apr;64(3-4):178-86.

7.

Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial.

Desai M, Gutman J, L'lanziva A, Otieno K, Juma E, Kariuki S, Ouma P, Were V, Laserson K, Katana A, Williamson J, ter Kuile FO.

Lancet. 2015 Dec 19;386(10012):2507-19. doi: 10.1016/S0140-6736(15)00310-4. Epub 2015 Sep 28.

PMID:
26429700
8.

Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women.

Hamer DH, Mwanakasale V, Macleod WB, Chalwe V, Mukwamataba D, Champo D, Mwananyanda L, Chilengi R, Mubikayi L, Mulele CK, Mulenga M, Thea DM, Gill CJ.

J Infect Dis. 2007 Dec 1;196(11):1585-94. Epub 2007 Oct 25.

9.

Intermittent preventive therapy for malaria in pregnancy: is sulfadoxine-pyrimethamine the right drug?

Parikh S, Rosenthal PJ.

Clin Pharmacol Ther. 2010 Feb;87(2):160-2. doi: 10.1038/clpt.2009.284.

PMID:
20107451
10.

The effect of intermittent preventive treatment during pregnancy on malarial antibodies depends on HIV status and is not associated with poor delivery outcomes.

Serra-Casas E, Menéndez C, Bardají A, Quintó L, Dobaño C, Sigauque B, Jiménez A, Mandomando I, Chauhan VS, Chitnis CE, Alonso PL, Mayor A.

J Infect Dis. 2010 Jan 1;201(1):123-31. doi: 10.1086/648595.

11.

Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection.

Parise ME, Ayisi JG, Nahlen BL, Schultz LJ, Roberts JM, Misore A, Muga R, Oloo AJ, Steketee RW.

Am J Trop Med Hyg. 1998 Nov;59(5):813-22.

12.

Protecting pregnant women from malaria in areas of high HIV infection prevalence.

Meshnick SR, Mwapasa V, Rogerson SJ.

J Infect Dis. 2006 Aug 1;194(3):273-5. Epub 2006 Jun 20. No abstract available.

13.

Cotrimoxazole prophylaxis versus mefloquine intermittent preventive treatment to prevent malaria in HIV-infected pregnant women: two randomized controlled trials.

Denoeud-Ndam L, Zannou DM, Fourcade C, Taron-Brocard C, Porcher R, Atadokpede F, Komongui DG, Dossou-Gbete L, Afangnihoun A, Ndam NT, Girard PM, Cot M.

J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):198-206. doi: 10.1097/QAI.0000000000000058.

PMID:
24220287
14.

Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial.

González R, Desai M, Macete E, Ouma P, Kakolwa MA, Abdulla S, Aponte JJ, Bulo H, Kabanywanyi AM, Katana A, Maculuve S, Mayor A, Nhacolo A, Otieno K, Pahlavan G, Rupérez M, Sevene E, Slutsker L, Vala A, Williamsom J, Menéndez C.

PLoS Med. 2014 Sep 23;11(9):e1001735. doi: 10.1371/journal.pmed.1001735. eCollection 2014 Sep.

15.

Intermittent preventive treatment regimens for malaria in HIV-positive pregnant women.

Mathanga DP, Uthman OA, Chinkhumba J.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD006689. doi: 10.1002/14651858.CD006689.pub2. Review.

PMID:
21975756
17.

The impact of intermittent preventive treatment with sulfadoxine-pyrimethamine on the prevalence of malaria parasitaemia in pregnancy.

Umeh UA, Obi SN, Onah HE, Ugwu EO, Ajah LO, Umeh CR, Okafor II.

Trop Doct. 2012 Jul;42(3):133-5. doi: 10.1258/td.2011.110402. Epub 2012 Mar 7.

PMID:
22399105
18.
19.

Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial.

González R, Mombo-Ngoma G, Ouédraogo S, Kakolwa MA, Abdulla S, Accrombessi M, Aponte JJ, Akerey-Diop D, Basra A, Briand V, Capan M, Cot M, Kabanywanyi AM, Kleine C, Kremsner PG, Macete E, Mackanga JR, Massougbodgi A, Mayor A, Nhacolo A, Pahlavan G, Ramharter M, Rupérez M, Sevene E, Vala A, Zoleko-Manego R, Menéndez C.

PLoS Med. 2014 Sep 23;11(9):e1001733. doi: 10.1371/journal.pmed.1001733. eCollection 2014 Sep.

20.

Placental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of Uganda.

Newman PM, Wanzira H, Tumwine G, Arinaitwe E, Waldman S, Achan J, Havlir D, Rosenthal PJ, Dorsey G, Clark TD, Cohan D.

Malar J. 2009 Nov 14;8:254. doi: 10.1186/1475-2875-8-254.

Items per page

Supplemental Content

Write to the Help Desk